Conversely, a lot of people think it’s a great time to come on board. The amount of equity options is a compelling reason to think longer term, easily can foresee a 5-10x over the next several years. It is apparent that many people here can’t sell very well, and that’s a fertile environment to step into as a true professional that can really make hay when much of the competition is weak. It is reassuring that management is apparently done with mediocrity, that bodes well for upgrading the field force.The only real concern with coming on board now is the looming potential for a buyout, but I’ve also been impressed with some of the potential suitors mentioned. I’ve also heard about acquiring a GLP-1 compound, very exciting and additive to the concept of lowering CVD burden. What’s not to like?